A detailed history of Ubs Oconnor LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Ubs Oconnor LLC holds 28,722 shares of ABT stock, worth $3.33 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares
28,722
Holding current value
$3.33 Million
% of portfolio
0.22%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$100.07 - $118.13 $1.97 Million - $2.33 Million
19,722 Added 219.13%
28,722 $3.27 Million
Q2 2024

Aug 14, 2024

BUY
$100.73 - $112.44 $906,570 - $1.01 Million
9,000 New
9,000 $935,000
Q4 2023

Feb 14, 2024

SELL
$90.19 - $110.4 $3.9 Million - $4.77 Million
-43,231 Reduced 88.23%
5,769 $634,000
Q3 2023

Nov 14, 2023

BUY
$95.53 - $114.62 $4.68 Million - $5.62 Million
49,000 New
49,000 $4.75 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $203B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Ubs Oconnor LLC Portfolio

Follow Ubs Oconnor LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Oconnor LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Oconnor LLC with notifications on news.